These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21800001)

  • 1. FXIII-A Leu34 genetic variant in premature coronary artery disease: a genotype--phenotype case control study.
    Silvain J; Pena A; Vignalou JB; Hulot JS; Galier S; Cayla G; Bellemain-Appaix A; Barthélémy O; Beygui F; Bal-dit-Sollier C; Drouet L; Weisel JW; Montalescot G; Collet JP
    Thromb Haemost; 2011 Sep; 106(3):511-20. PubMed ID: 21800001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor XIII Val34Leu polymorphism as a modulator of fibrin clot permeability and resistance to lysis in patients with severe coronary artery disease.
    Stepień E; Plicner D; Kapelak B; Wypasek E; Sadowski J; Undas A
    Kardiol Pol; 2009 Aug; 67(8A):947-55. PubMed ID: 19784898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of FXIII-A Val34Leu polymorphism on coronary artery disease in Croatian patients.
    Bronić A; Ferencak G; Zadro R; Stavljenić-Rukavina A; Bernat R
    Mol Biol Rep; 2009 Jan; 36(1):1-5. PubMed ID: 17899444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
    Bereczky Z; Balogh E; Katona E; Czuriga I; Kárpáti L; Shemirani AH; Edes I; Muszbek L
    Thromb Res; 2008; 121(4):469-76. PubMed ID: 17597187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease.
    Kreutz RP; Bitar A; Owens J; Desta Z; Breall JA; von der Lohe E; Sinha A; Vatta M; Nystrom P; Jin Y; Flockhart DA
    J Thromb Thrombolysis; 2014 Oct; 38(3):380-7. PubMed ID: 24510702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.
    Marín F; González-Conejero R; Lee KW; Corral J; Roldán V; López F; Sogorb F; Caturla J; Lip GY; Vicente V
    J Am Coll Cardiol; 2005 Jan; 45(1):25-9. PubMed ID: 15629368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between factor XIII Val34Leu polymorphism and early myocardial infarction.
    Hancer VS; Diz-Kucukkaya R; Bilge AK; Ozben B; Oncul A; Ergen G; Nalcaci M
    Circ J; 2006 Mar; 70(3):239-42. PubMed ID: 16501286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population.
    Bereczky Z; Balogh E; Katona E; Pocsai Z; Czuriga I; Széles G; Kárpáti L; Adány R; Edes I; Muszbek L
    Thromb Res; 2007; 120(4):567-73. PubMed ID: 17250879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years.
    Rallidis LS; Politou M; Komporozos C; Panagiotakos DB; Belessi CI; Travlou A; Lekakis J; Kremastinos DT
    Thromb Haemost; 2008 Jun; 99(6):1085-9. PubMed ID: 18521512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XIII-A subunit Val34Leu polymorphism in fatal atherothrombotic ischemic stroke.
    Shemirani AH; Antalfi B; Pongrácz E; Mezei ZA; Bereczky Z; Csiki Z
    Blood Coagul Fibrinolysis; 2014 Jun; 25(4):364-8. PubMed ID: 24686102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined carrier status of prothrombin 20210A and factor XIII-A Leu34 alleles as a strong risk factor for myocardial infarction: evidence of a gene-gene interaction.
    Butt C; Zheng H; Randell E; Robb D; Parfrey P; Xie YG
    Blood; 2003 Apr; 101(8):3037-41. PubMed ID: 12480694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of genetic variants of hemostatic genes with myocardial infarction in Egyptian patients.
    El-Fattah AAA; Sadik NAH; Sedrak H; Battah A; Nabil M
    Gene; 2018 Jan; 641():212-219. PubMed ID: 29054763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation factor XIII-A Val34Leu polymorphism and the risk of coronary artery disease and myocardial infarction in a Chinese Han population.
    Guodong Jin ; Beili Feng ; Peng Chen ; Oushan Tang ; Jian Wang ; Ji Ma ; Yuping Shi ; Geng Xu
    Clin Appl Thromb Hemost; 2011 Apr; 17(2):208-13. PubMed ID: 20211923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
    Gemmati D; Serino ML; Ongaro A; Tognazzo S; Moratelli S; Resca R; Moretti M; Scapoli GL
    Am J Hematol; 2001 Jul; 67(3):183-8. PubMed ID: 11391716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XIII Val34Leu polymorphism and gamma-chain cross-linking at the site of microvascular injury in healthy and coumadin-treated subjects.
    Undas A; Brzezinska-Kolarz B; Brummel-Ziedins K; Musial J; Szczeklik A; Mann KG
    J Thromb Haemost; 2005 Sep; 3(9):2015-21. PubMed ID: 16102108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males.
    Wartiovaara U; Perola M; Mikkola H; Tötterman K; Savolainen V; Penttilä A; Grant PJ; Tikkanen MJ; Vartiainen E; Karhunen PJ; Peltonen L; Palotie A
    Atherosclerosis; 1999 Feb; 142(2):295-300. PubMed ID: 10030380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of factor XIII Val34Leu polymorphism and coronary artery disease: A meta-analysis.
    Jung JH; Song GG; Kim JH; Seo YH; Choi SJ
    Cardiol J; 2017; 24(1):74-84. PubMed ID: 27665853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
    de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
    Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen plasma levels modify the association between the factor XIII Val34Leu variant and risk of coronary artery disease: the EPIC-Norfolk prospective population study.
    Boekholdt SM; Sandhu MS; Wareham NJ; Luben R; Reitsma PH; Khaw KT
    J Thromb Haemost; 2006 Oct; 4(10):2204-9. PubMed ID: 16881935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XIII B subunit polymorphisms and the risk of coronary artery disease.
    Mezei ZA; Bereczky Z; Katona É; Gindele R; Balogh E; Fiatal S; Balogh L; Czuriga I; Ádány R; Édes I; Muszbek L
    Int J Mol Sci; 2015 Jan; 16(1):1143-59. PubMed ID: 25569091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.